1. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Issue 23 (22nd August 2017) Authors: Dorff, Tanya B.; Longmate, Jeff A.; Pal, Sumanta K.; Stadler, Walter M.; Fishman, Mayer N.; Vaishampayan, Ulka N.; Rao, Amol; Pinksi, Jacek K.; Hu, James S.; Quinn, David I.; Lara, Primo N. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗